Skip to main content
Touchstone International Medical Science Co., Ltd. logo

Touchstone International Medical Science Co., Ltd. — Investor Relations & Filings

Ticker · 688013 ISIN · CNE1000042J3 LEI · 300300OELXQ5COBRMA79 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 636 across all filing types
Latest filing 2026-05-26 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 688013

About Touchstone International Medical Science Co., Ltd.

http://www.touchstonesurgical.com/

Touchstone International Medical Science Co., Ltd. specializes in the research, development, and manufacturing of advanced surgical stapling instruments. The company focuses on providing high-quality solutions for minimally invasive and open surgical procedures. Its product portfolio includes a comprehensive range of circular staplers, linear cutters, endoscopic staplers, and hemorrhoidal staplers, along with specialized reloads. These instruments are designed to enhance surgical precision, improve clinical outcomes, and streamline operative workflows. By integrating innovative engineering with rigorous quality control, the company serves healthcare providers globally, addressing complex surgical needs in gastrointestinal, thoracic, and general surgery. The organization emphasizes continuous technological advancement to support surgeons in delivering safer and more efficient patient care.

Recent filings

Filing Released Lang Actions
天臣医疗关于以集中竞价交易方式首次回购公司股份的公告
Transaction in Own Shares Classification · 98% confidence The document is an announcement by Tianchen International Medical Technology Co., Ltd. regarding the first repurchase of its own shares through centralized bidding, detailing the number of shares repurchased, prices, total amount, purpose, and dates. This is a transaction in the company’s own shares (share buyback).
2026-05-26 Chinese
天臣医疗关于2023年限制性股票激励计划第三个归属期归属结果公告
Transaction in Own Shares Classification · 75% confidence The document is a formal announcement (“公告”) by a listed company on the vesting results of its 2023 restricted stock incentive plan, detailing the number of treasury shares (repurchased A-shares) to be allocated to directors, managers and other employees. Although the company repurchased shares earlier, this announcement concerns the sale/issuance of those own shares to plan participants. There is no change in registered capital (so it is not a capital increase announcement), and it is not an earnings report, dividend notice, or proxy statement. Under our taxonomy, “Transaction in Own Shares” (code POS) covers the company’s sale or disposal of treasury shares.
2026-05-22 Chinese
天臣医疗2026年员工持股计划管理办法
Governance Information Classification · 91% confidence The document is the detailed management measures (“管理办法”) for the company's 2026 employee stock ownership plan, setting out internal procedures, governance bodies, rights and obligations, approval processes, etc. It is not a financial report or an announcement of results, but rather a governance charter detailing internal rules and structures. Such internal governance documents fall under the Governance Information category (CGR).
2026-05-18 Chinese
董事会薪酬与考核委员会关于公司2026年员工持股计划相关事项的核查意见
Regulatory Filings Classification · 75% confidence The document is a formal compliance opinion issued by the Board’s Compensation and Assessment Committee regarding the company’s 2026 Employee Stock Ownership Plan draft, confirming it meets legal and regulatory requirements. It does not present actual financial statements, earnings, nor does it directly announce key capital issuance details (e.g., number of shares, pricing). It is not an annual/interim report, proxy statement, dividend notice, or any of the more specific categories. As an internal regulatory compliance filing that does not fit another specialty category, it falls under the general “Regulatory Filings” classification.
2026-05-18 Chinese
天臣医疗第三届董事会第四次会议决议公告
Board/Management Information Classification · 82% confidence The document is an announcement of the resolutions from the company’s Board of Directors (the third board’s fourth meeting), detailing procedural notices, voting results, and items approved by the board (e.g., employee share plan and related authorizations). This is not a full financial report, proxy solicitation, or dividend notice; it is a board meeting resolution announcement. The closest category is Board/Management Information (MANG).
2026-05-18 Chinese
第三届董事会独立董事专门会议2026年第一次会议审查意见
Governance Information Classification · 55% confidence The document is the formal opinions of the company’s independent directors issued at a specialized board meeting reviewing the 2026 Employee Share Ownership Plan and its management rules. It does not announce management or board changes (MANG), nor is it an earnings release, dividend, or financing update. It is a governance‐related board document outlining internal review and compliance with corporate law and exchange rules, fitting under the Governance Information category (CGR).
2026-05-18 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.